Low density lipoprotein oxidation, antioxidants, and atherosclerosis.
Oxidized low density lipoproteins (LDLs) are believed to be the most atherogenic form of LDL. However, although a number of experimental data support this concept, the protective role of antioxidants that may prevent LDL oxidation in atherosclerosis is only partially confirmed by studies in humans. Observational and epidemiologic data as well as randomized trials failed to provide clear-cut indications because of mixed results on the protective role of antioxidants against cardiovascular diseases. In spite of the lack of a general consensus, recent data reinforce the concept that a regular intake of antioxidants present in food blocks the progression of atherosclerosis and that the reduced oxidisability of LDL may represent a good marker to follow the action of antioxidants. When it becomes possible to monitor the efficacy of any antioxidant therapy with validated markers of oxidation, the potential influence of vitamins and antioxidants on coronary artery disease will eventually be resolved.
Catapano
A L
AL
Institute of Pharmacological Sciences, University of Milan, Italy. alberico.catapano@unimi.it
Maggi
F M
FM
Tragni
E
E
D000975:Antioxidants / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000378:metabolism* / Q000517:prevention & control*; D006801:Humans; D008077:Lipoproteins, LDL / Q000378:metabolism*; D008297:Male; D010084:Oxidation-Reduction; D016032:Randomized Controlled Trials as Topic
D000975:Antioxidants; D008077:Lipoproteins, LDL